Financial statements Private Label Tissue
Cash inflows of PRIVATE LABEL TISSUE
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Net cash from operating expenses | 291 978,58 | 2 613 100,22 | -1 536 571,46 | -2 528 663,50 | 4 841 462,34 | 22 949 423,78 |
Net cash flow from investing activities | -38 720,73 | -3 462 159,52 | -3 485 234,40 | -58 685,00 | -123 944,55 | -1 236 283,90 |
Net cash flow from financial activities | -254 610,60 | 1 004 798,84 | 4 964 854,81 | 2 504 223,65 | -4 600 298,63 | -15 378 199,24 |
Total net cash flow | -1 352,75 | 155 739,54 | -56 951,05 | -83 124,85 | 117 219,16 | 6 334 940,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.